Oliver Fetzer

Oliver Fetzer

Directeur/Membre du Conseil chez TECAN GROUP AG

Fortune : 670 248 $ au 31/05/2026

62 ans
Health Technology
Consumer Services
Commercial Services

Profil

Oliver Steffen Fetzer currently works at Viridos, Inc., as Chief Executive Officer & Director from 2014 and Tecan Group AG, as Non-Executive Director from 2011.
Dr. Fetzer also formerly worked at Cerulean Pharma, Inc., as President, Chief Executive Officer & Director from 2009 to 2014, Arena Pharmaceuticals, Inc., as Independent Director from 2017 to 2022, Auxilium Pharmaceuticals LLC, as Independent Director from 2005 to 2015, The Boston Consulting Group, Inc., as Managing Director & Partner from 2000 to 2002, Cubist Pharmaceuticals LLC, as Senior Vice President-Research & Development from 2002 to 2007, and Bayer AG, as Principal.
Dr. Fetzer received his Masters Business Admin degree from Carnegie Mellon University, doctorate degree from The Medical University of South Carolina, and undergraduate degree from College of Charleston.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2024 3 370 ( 0,03 % ) 670 248 $ 31/05/2026

Postes actifs de Oliver Fetzer

SociétésPosteDébut
TECAN GROUP AG Directeur/Membre du Conseil 19/04/2011
Directeur Général 27/10/2014

Anciens postes connus de Oliver Fetzer

SociétésPosteFin
ARENA PHARMACEUTICALS Directeur/Membre du Conseil 11/03/2022
AUXILIUM PHARMACEUTICALS, INC. Directeur/Membre du Conseil 29/01/2015
Directeur Général 29/10/2014
CUBIST PHARMACEUTICALS INC Directeur Technique/Scientifique/R&D 01/01/2007
Corporate Officer/Principal 01/01/2002
Voir l'expérience en détail de Oliver Fetzer

Formation de Oliver Fetzer

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

77

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Oliver Fetzer
🔇